[Analysis of treatment response and prognostic factors of T-LBL patients treated with pediatric-like ALL therapy following HSCT].

Wang, H T; Dong, Y; Gao, X T; Wan, Z; Zhao, Y X; Liu, Y M; Liu, L

Wang, H T; Dong, Y; Gao, X T; Wan, Z; Zhao, Y X; Liu, Y M; Liu, L.

Afiliación

Wang HT; Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
Dong Y; Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
Gao XT; Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
Wan Z; Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
Zhao YX; Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
Liu YM; Department of Nutrition and Food Safety, Xi'an Jiaotong University, Xi'an 710049, China.
Liu L; Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.

Zhonghua Xue Ye Xue Za Zhi ; 41(5): 387-393, 2020 May 14.

Article en Zh | MEDLINE | ID: mdl-32536135

Asunto(s)

Trasplante de Células Madre Hematopoyéticas; Leucemia-Linfoma Linfoblástico de Células Precursoras; Niño; Supervivencia sin Enfermedad; Humanos; Pronóstico; Estudios Retrospectivos; Resultado del Tratamiento

Palabras clave

Antineoplastic combined chemotherapy protocols; Hematopoietic stem cell transplantation; Prognosis; T-lymphoblastic lymphoma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google